D. E. Shaw & Co., Inc. Alkermes Plc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 555,683 shares of ALKS stock, worth $16.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

555,683

Holding current value

$16.4 Million

% of portfolio

0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $5.35 Million - $6.64 Million	232,542 Added 71.96%	555,683 $15.6 Million
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $434,027 - $509,387	-18,700 Reduced 5.47%	323,141 $7.79 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $7.83 Million - $9.66 Million	-296,592 Reduced 46.46%	341,841 $9.25 Million
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $7.62 Million - $9.35 Million	-326,161 Reduced 33.81%	638,433 $17.7 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $7.69 Million - $9.05 Million	282,975 Added 41.52%	964,594 $27 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $6.73 Million - $7.98 Million	237,339 Added 53.42%	681,619 $21.3 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $3.22 Million - $3.69 Million	-127,074 Reduced 22.24%	444,280 $12.5 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $7.09 Million - $8.48 Million	323,112 Added 130.16%	571,354 $14.9 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $585,618 - $848,347	-26,619 Reduced 9.68%	248,242 $5.54 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $5.68 Million - $6.57 Million	215,019 Added 359.31%	274,861 $8.19 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $2.98 Million - $3.61 Million	-129,056 Reduced 68.32%	59,842 $1.57 Million
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $2.4 Million - $3.59 Million	111,804 Added 145.02%	188,898 $4.39 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $2.32 Million - $3.2 Million	-99,443 Reduced 56.33%	77,094 $2.38 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $2.08 Million - $2.78 Million	110,626 Added 167.84%	176,537 $4.33 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $6.21 Million - $7.92 Million	-341,185 Reduced 83.81%	65,911 $1.23 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $4.74 Million - $6.81 Million	-308,034 Reduced 43.07%	407,096 $8.12 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $2.33 Million - $2.98 Million	144,141 Added 25.24%	715,130 $11.9 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $4.01 Million - $5.85 Million	-301,503 Reduced 34.56%	570,989 $11.1 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $2.43 Million - $3.96 Million	-186,446 Reduced 17.61%	872,492 $12.6 Million
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $6.93 Million - $8.71 Million	400,652 Added 60.86%	1,058,938 $21.6 Million
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $2.98 Million - $3.7 Million	-152,535 Reduced 18.81%	658,286 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $9.94 Million - $17.3 Million	463,063 Added 133.16%	810,821 $18.3 Million
Q1 2019 May 15, 2019	BUY	$28.4 - $36.49 $6.61 Million - $8.5 Million	232,885 Added 202.73%	347,758 $12.7 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $62,250 - $99,391	2,228 Added 1.98%	114,873 $3.39 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $2.14 Million - $2.56 Million	55,463 Added 96.99%	112,645 $4.78 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $827,991 - $1.05 Million	-20,414 Reduced 26.31%	57,182 $2.35 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $5.71 Million - $7.17 Million	-106,548 Reduced 57.86%	77,596 $4.5 Million
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $17.6 Million - $20.4 Million	-368,158 Reduced 66.66%	184,144 $10.1 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $27.2 Million - $30.1 Million	552,302	552,302 $28.1 Million

Others Institutions Holding ALKS

# of Institutions

360

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.84B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account